2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

»çȸ¹®Á¦¸¦ ÇØ°áÇϴ û³â 478¸íÀÇ ¡®º£À̽ºÄ·ÇÁ¡¯°¡ µÇ´Ù

10³â°£ 478¸íÀÇ ¼ö·á»ý ¹èÃ⡦ ÀÓÆÑÆ® »ýŰè ÀÎÀç µî¿ë¹® ¿ªÇÒ
ºñ¿µ¸® »ç´Ü¹ýÀÎ ·çÆ®ÀÓÆÑÆ®°¡ ‘ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ(Impact Basecamp)’ ÇÁ·Î±×·¥ 10ÁÖ³âÀ» ¸Â¾Æ ¼ö·á»ýÀÇ º¯È­¿Í ÇÁ·Î±×·¥ÀÇ ¼º°ú¸¦ ´ãÀº ÀÓÆÑÆ® ¸®Æ÷Æ®¸¦ ¹ß°£ÇÏ°í ±â³äÇà»ç¸¦ °³ÃÖÇß´Ù. ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ´Â û³âµéÀÌ »çȸ¹®Á¦¸¦ ÇØ°áÇÏ´Â ¿ª·®À» ±â¸£°í, À̸¦ Ä¿¸®¾î ¼ºÀå°ú ¿¬°èÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â ±³À° ÇÁ·Î±×·¥ÀÌ´Ù. ¾à 8ÁÖ~16ÁÖ°£ »çȸ¹®Á¦¸¦ Á¤ÀÇÇϰí Á÷Á¢ ¹®Á¦ ÇØ°á ¹æ¹ýÀ» µµÃâÇÏ´Â ÇÁ·ÎÁ§Æ® ±â¹Ý ÇнÀ(Project Based Learning, PBL) ¹æ½ÄÀ¸·Î ÁøÇàµÈ´Ù. 2015³â ½ÃÀÛÇÑ ÀÌ·¡ ÇöÀç±îÁö 478¸íÀÇ ¼ö·á»ýÀ» ¹èÃâ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Ãâ±ÙÇÏ´Â ±×¸®½ºµµÀο¡°Ô (2016-12-15)
¼ö¼ú ¾øÀÌ ¹é³â °¡´Â °­ÇÑ Ç㸮 ¸¸µé±â (2017-02-21)
Institutional PIPE Investor With $2bn in Executed Financing ... (2023-02-27)
¡®³ª´Â SOLO¡¯ ±¤¼ö-¿Á¼ø-¿µÃ¶, ½É¾ßÀÇ »ïÀÚ´ë¸é (2023-09-20)
¾Èµ¿¼ÒÁÖ, ½ºÅ¸Æ®¾÷°ú ÇÔ²² ÇÏÀ̺¼½ÃÀå ÁøÀÔ º»°ÝÈ­ (2023-11-02)
[»ê¾÷] µð½ºÇ÷¹ÀÌÀÇ ´º ÇÁ·ÐƼ¾î, ÀÚµ¿Â÷ (2015-06-24)
ÆÄÀÎÀÎÆ÷, ²Î ¾ø´Â 100%´ç÷ ¡®·ÎÁöÅØ ·°Å°µå·Î¿ì¡¯ ½Ç½Ã (2024-07-07)
Canva Celebrates 10th Anniversary With Launch of World¡¯s Fi... (2023-10-05)
[°æÁ¦] Á¦µµ °³¼± ¾øÀÌ Àå±âÁö¼Ó ¼ºÀå ¾î·Æ´Ù (2015-09-09)
½á¸ð½º º£½ºÆ®¼¿·¯ Ű¿öµå ¡®Ä¿½ºÅÒ, ½Ä¼¼±â, ½º¸ô »çÀÌÁ (2024-06-04)
ij³ª´ÙÇà Ç×°øÆí¿¡ ž½Â, ÀüÀÚ¿©ÇàÇã°¡ ÇÊ¿ä (2016-03-09)
½Å¿¹ äºó, ¡®Áß¼¼½Ã´ë¡¯ ¹Ì³à·Î ±ô¦ º¯½Å (2017-06-18)
ÇϳªÀºÇà, À̸Ó¡¸¶ÄÏ ÇØ¿Ü¼Û±Ý ±â¾÷ ¡®Áö¿ªÆ¯È­¼Û±Ý¡¯ ¼­ºñ½º (2024-07-17)
¡®³ª´Â SOLO¡¯ ÇÏ´ÃÀÌ ³»¸° ¡®·Î¶Ç¡¯±Þ ¦ ³ª¿Ô´Ù? (2024-07-17)
Á×Çâ ÀÌ»ý°­ ¸íÀÎ ¡®±¸Àü½É¼ö 82³â Á£´ë¼Ò¸®¡¯ °ø¿¬ ¿­¾î (2024-05-02)
³ë½ºÆäÀ̽º, ¡®³Ã°¨ ÀÇ·ù¡¯ ½ÅÁ¦Ç° Ãâ½Ã (2024-05-07)
Çϸ² ¡®ÀÚ¿¬½Ç·Ï µ¿¹°º¹Áö ´ß°¥ºñ¡¯ 3Á¾ (2023-08-20)
½ÅÇÑÄ«µå, CJ ONE¿Í ¡®CJ ONE ÇÁ¸®Áò ½ÅÇÑÄ«µå¡¯ Ãâ½Ã (2023-09-27)
±â´É¼º Ŭ¸° ºäƼ ºê·£µå ¿¢½Ã½º¿ÍÀÌ Ã»´ã »ç¿Á ¼Ò°³ (2024-03-02)
PUMA Launches Major Brand Campaign to Strengthen Sports Perf... (2024-04-14)
Crayon Hits 3 Key Steps on AWS Winning Streak (2024-10-16)
Black & Veatch Addresses Southeast Asia¡¯s Growing Energy Tr... (2024-10-16)
¹«´õÀ§ ³¯·Á¹ö¸± ÆÇ¸ð¹Ð ³Ã¸ð¹Ð ºñºö¸ð¹Ð (2015-05-20)
ºÎ¸¶¹ÎÁÖÇ×Àï ´ãÀº ¡®¸¸È­·Î º¸´Â ¹ÎÁÖÈ­¿îµ¿: ºÒ¾¾¡¯ ¹ß°£ (2024-05-27)
A Journey Through Time: The Evolution of Ras Al Khaimah Art (2024-03-17)
       [ÀÌÀü][1]....[695][696][697][698][699][700][701][702][703]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..